Problems oral problems in chronic renal dialysis patients
DOI:
https://doi.org/10.35381/s.v.v8i1.3719Keywords:
Oral health, oral hygiene, dental care, (Source: DeCS)Abstract
Objective: to identify oral problems in chronic renal dialysis patients. Method: Descriptive observational documentary. Conclusion: As an innovative factor, the formulation of a new mouthwash/gel/gingival paste, with a high content of polyphenols in association with NBC characterized by an antimicrobial action, could represent a future therapy for oral disease in CKD patients.
Downloads
References
Webster AC, Nagler EV, Morton RL, Masson P. Chronic Kidney Disease. Lancet. 2017;389(10075):1238-1252. http://dx.doi.org/10.1016/S0140-6736(16)32064-5
Ruiz Ortega M, Rayego Mateos S, Lamas S, Ortiz A, Rodrigues Diez RR. Targeting the progression of chronic kidney disease. Nat Rev Nephrol. 2020;16(5):269-288. http://dx.doi.org/10.1038/s41581-019-0248-y
Naber T, Purohit S. Chronic Kidney Disease: Role of Diet for a Reduction in the Severity of the Disease. Nutrients. 2021;13(9):3277. http://dx.doi.org/10.3390/nu13093277
Chan W. Chronic Kidney Disease and Nutrition Support. Nutr Clin Pract. 2021;36(2):312-330. doi:10.1002/ncp.10658 VanSickle JS, Warady BA. Chronic Kidney Disease in Children. Pediatr Clin North Am. 2022;69(6):1239-1254. http://dx.doi.org/10.1016/j.pcl.2022.07.010
Panzarino V, Lesser J, Cassani FA. Pediatric Chronic Kidney Disease. Adv Pediatr. 2022;69(1):123-132. http://dx.doi.org/10.1016/j.yapd.2022.03.008
Wang YN, Ma SX, Chen YY, et al. Chronic kidney disease: Biomarker diagnosis to therapeutic targets. Clin Chim Acta. 2019;499:54-63. http://dx.doi.org/10.1016/j.cca.2019.08.030
Agarwal P, Garg V, Karagaiah P, Szepietowski JC, Grabbe S, Goldust M. Chronic Kidney Disease-Associated Pruritus. Toxins (Basel). 2021;13(8):527. http://dx.doi.org/10.3390/toxins13080527
Valle Flores JA, Fariño Cortéz JE, Mayner Tresol GA, Perozo Romero J, Blasco Carlos M, Nestares T. Oral supplementation with omega-3 fatty acids and inflammation markers in patients with chronic kidney disease in hemodialysis. Appl Physiol Nutr Metab. 2020;45(8):805-811. http://dx.doi.org/10.1139/apnm-2019-0729
Chávez-Iñiguez JS, Zaragoza JJ, Camacho-Guerrero JR, et al. Systolic Blood Pressure and the Risk of Kidney Replacement Therapy and Mortality in Patients with Chronic Kidney Disease Stages 4-5. Kidney Blood Press Res. 2023;48(1):556-567. http://dx.doi.org/10.1159/000533438
Torres I, Sippy R, Bardosh KL, et al. Chronic kidney disease in Ecuador: An epidemiological and health system analysis of an emerging public health crisis. PLoS One. 2022;17(3):e0265395. http://dx.doi.org/10.1371/journal.pone.0265395
Bots CP, Poorterman JH, Brand HS, et al. The oral health status of dentate patients with chronic renal failure undergoing dialysis therapy. Oral Dis. 2006;12(2):176-180. http://dx.doi.org/10.1111/j.1601-0825.2005.01183.x
Xie T, Deng MZ, Kang J, Chen K, Yao JF, Cang-Shang Z. Shanghai Kou Qiang Yi Xue. 2023;32(5):541-544.
Basilicata M, Pieri M, Marrone G, et al. Saliva as Biomarker for Oral and Chronic Degenerative Non-Communicable Diseases. Metabolites. 2023;13(8):889. Published 2023 Jul 27. http://dx.doi.org/10.3390/metabo13080889
Basilicata M, Di Lauro M, Campolattano V, et al. Natural Bioactive Compounds in the Management of Oral Diseases in Nephropathic Patients. Int J Environ Res Public Health. 2022;19(3):1665. http://dx.doi.org/10.3390/ijerph19031665
Yuan Q, Xiong QC, Gupta M, et al. Dental implant treatment for renal failure patients on dialysis: a clinical guideline. Int J Oral Sci. 2017;9(3):125-132. http://dx.doi.org/10.1038/ijos.2017.23
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Johan Sebastian García-Andrade, Crisley Sabyne Varela-Cando, Galo Francisco Alarcón-Morán, Jonathan Armando Yanza-Freire

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
CC BY-NC-SA : Esta licencia permite a los reutilizadores distribuir, remezclar, adaptar y construir sobre el material en cualquier medio o formato solo con fines no comerciales, y solo siempre y cuando se dé la atribución al creador. Si remezcla, adapta o construye sobre el material, debe licenciar el material modificado bajo términos idénticos.
OAI-PMH: https://fundacionkoinonia.com.ve/ojs/index.php/saludyvida/oai.



